RNA Aptamers to Translational Components

被引:6
|
作者
Nakamura, Yoshikazu [1 ]
Endo, Kei [1 ]
Adachi, Hironori [1 ]
Ishiguro, Akira [1 ]
机构
[1] Univ Tokyo, Dept Basic Med Sci, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan
基金
日本科学技术振兴机构;
关键词
INITIATION-FACTOR; 4E; CAP-DEPENDENT TRANSLATION; FACTOR 4G EIF4G; BINDING PROTEIN EIF4E; RIBOSOMAL ENTRY SITE; MAMMARY-TUMOR VIRUS; DENDRITIC BC1 RNA; MESSENGER-RNA; EUKARYOTIC TRANSLATION; FACTOR; 4A;
D O I
10.1016/S1877-1173(09)90010-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Potential applications for functional RNAs are rapidly expanding, not only to address functions based on primary nucleotide sequences, but also by RNA aptamers, which can suppress the activity of any target molecule. Aptamers are short DNA or RNA folded molecules that can be selected in vitro on the basis of their high affinity for a target molecule. Here, we summarize RNA aptamers selected against human translation initiation factors, and their superior potentials to recognize and inhibit their target proteins. Importantly, the high affinity of RNA aptamers to proteins without RNA recognition motifs or intrinsic, strong affinity to RNA is achieved through the capture of the protein's global conformation. In other words, RNA has a high potential to form a vast set of tertiary structures, which we would like to refer to as 'RNA plasticity'. This provides us with a solid and promising basis to take steps to create novel RNA molecules of therapeutic potential with distinct structures, which should be equivalent or superior to antibodies.
引用
收藏
页码:369 / 395
页数:27
相关论文
共 50 条
  • [21] Therapeutic RNA aptamers in clinical trials
    Sundaram, Padma
    Kurniawan, Helena
    Byrne, Mark E.
    Wower, Jacek
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (1-2) : 259 - 271
  • [22] RNA and DNA aptamers in cytomics analysis
    Ulrich, H
    Martins, AHB
    Pesquero, JB
    [J]. CYTOMETRY PART A, 2004, 59A (02) : 220 - 231
  • [23] Structural Principles of Fluorescent RNA Aptamers
    Trachman, Robert J., III
    Truong, Lynda
    Ferre-D'Amare, Adrian R.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (10) : 928 - 939
  • [24] FRET Systems with RNA Fluorescent Aptamers
    Thomsen, Sofie
    Andersen, Maria Illum
    Vallina, Nestor Sampedro
    Andersen, Ebbe Sloth
    Birkedal, Victoria
    [J]. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2023, 52 (SUPPL 1): : S209 - S209
  • [25] Aptamers and the RNA World, Past and Present
    Gold, Larry
    Janjic, Nebojsa
    Jarvis, Thale
    Schneider, Dan
    Walker, Jeffrey J.
    Wilcox, Sheri K.
    Zichi, Dom
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2012, 4 (03):
  • [26] RAPID-SELEX for RNA Aptamers
    Szeto, Kylan
    Latulippe, David R.
    Ozer, Abdullah
    Pagano, John M.
    White, Brian S.
    Shalloway, David
    Lis, John T.
    Craighead, Harold G.
    [J]. PLOS ONE, 2013, 8 (12):
  • [27] DNA/RNA Aptamers and Their Applications in Electroanalysis
    Hianik, Tibor
    [J]. ELECTROANALYSIS, 2009, 21 (11) : 1221 - 1222
  • [28] Isolation of RNA aptamers to block coagulation
    Sullenger, B
    Rusconi, C
    Yeh, A
    Lawson, J
    Lyerly, H
    [J]. FASEB JOURNAL, 1999, 13 (07): : A1320 - A1320
  • [29] Therapeutic Applications of DNA and RNA Aptamers
    Thiel, Kristina W.
    Giangrande, Paloma H.
    [J]. OLIGONUCLEOTIDES, 2009, 19 (03) : 209 - 222
  • [30] A Branched SELEX Approach Identifies RNA Aptamers That Bind Distinct HIV-1 Capsid Structural Components
    Gruenke, Paige R.
    Mayer, Miles D.
    Aneja, Rachna
    Schulze, William J.
    Song, Zhenwei
    Burke, Donald H.
    Heng, Xiao
    Lange, Margaret J.
    [J]. ACS INFECTIOUS DISEASES, 2024, 10 (08): : 2637 - 2655